[Influenza viruses and SARS-CoV-2, are we ready for the future?]
Virus grippaux et Sars-CoV-2, sommes-nous prêts pour le futur ?
SARS-CoV-2
diagnosis
emergence
influenza
respiratory virus
Journal
Actualites pharmaceutiques
ISSN: 0515-3700
Titre abrégé: Actual Pharm
Pays: France
ID NLM: 0043545
Informations de publication
Date de publication:
Jul 2021
Jul 2021
Historique:
entrez:
31
8
2021
pubmed:
1
9
2021
medline:
1
9
2021
Statut:
ppublish
Résumé
Influenza viruses and severe acute respiratory syndrome coronavirus 2 are respiratory viruses with a high potential for evolution. Their circulation must be carefully monitored.. The development of diagnostic tools, as well as the search for universal vaccines and new treatments, are strategic tools in public health that allow us to be ready to face future emergencies.
Identifiants
pubmed: 34462618
doi: 10.1016/j.actpha.2021.06.009
pii: S0515-3700(21)00293-7
pmc: PMC8387106
doi:
Types de publication
English Abstract
Journal Article
Langues
fre
Pagination
28-35Informations de copyright
© 2021 Elsevier Masson SAS. All rights reserved.
Références
Emerg Microbes Infect. 2020 Dec;9(1):221-236
pubmed: 31987001
Int J Biol Sci. 2020 Mar 15;16(10):1686-1697
pubmed: 32226286
Trends Microbiol. 2016 Jun;24(6):490-502
pubmed: 27012512
Methods Mol Biol. 2018;1836:1-21
pubmed: 30151566
MMWR Morb Mortal Wkly Rep. 2021 Jan 22;70(3):95-99
pubmed: 33476315
Biomolecules. 2020 Sep 11;10(9):
pubmed: 32933047
Diagnostics (Basel). 2020 May 09;10(5):
pubmed: 32397487
J Clin Med. 2020 Apr 24;9(4):
pubmed: 32344679
Nucleic Acids Res. 2018 Jan 4;46(D1):D708-D717
pubmed: 29040670
Nat Microbiol. 2020 Apr;5(4):536-544
pubmed: 32123347
Virulence. 2017 Nov 17;8(8):1580-1591
pubmed: 28812422
Science. 2020 Mar 27;367(6485):1444-1448
pubmed: 32132184
Med Sci (Paris). 2020 Nov;36(11):1034-1037
pubmed: 33151866
Virus Res. 2004 Jul;103(1-2):55-60
pubmed: 15163489